Status:
UNKNOWN
Evaluation of Different Imaging Modalities in Regional Lymph Nodes Staging in Patients With Breast Cancer
Lead Sponsor:
Mennatallah Arous Mohamed
Conditions:
Breast Carcinoma Metastatic in Lymph Node
Eligibility:
FEMALE
25-65 years
Brief Summary
The regional lymph node status is considered to be an important prognostic factor regarding the long-term survival of breast cancer (BC) patients (Cetin IA, et al . 2020). The knowledge of whether lym...
Detailed Description
The following data will be collected from electronic or paper medical data records as: 1\) Age 2 )Sex 3)Family history of breast cancer 4)Menopausal status 5 )Body mass index (BMI) 6) Histological ty...
Eligibility Criteria
Inclusion
- Patient consenting to participate in the study.
- Patients who can tolerate the imaging modalities and have proven to tolerate the contrast agents . 3) Breast cancer patients coming for an initial assessment with or without clinical regional lymph nodes positive status.
- 4\) Breast cancer patients planned to have(breast-conserving surgery or mastectomy)as well as lymph node surgeries(sentinel lymph node v biopsy and/or axillary lymph node dissection.
Exclusion
- 1)Patients denying consent to participate in the study 2) Patients who are not fit for further imaging evaluation (patients who exceed the weight limit, patients who are sensitive to contrast material, etc). 3) Patients with bilateral MRM and AC
- \-
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 12 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT06185946
Start Date
January 1 2024
End Date
January 12 2025
Last Update
December 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute
Cairo, Egypt, 007